Bronchodilatory effect of the PPAR-γ agonist rosiglitazone in smokers with asthma

Clinical Pharmacology and Therapeutics

Volumn 86, Issue 1, 2009, Pages 49-53

  Spears, M ^a   Donnelly, I ^a   Jolly, L ^a   Brannigan, M ^a   Ito, K ^b   McSharry, C ^a   Lafferty, J ^a   Chaudhuri, R ^a   Braganza, G ^a   Bareille, P ^c   Sweeney, L ^c   Adcock, I M ^b   Barnes, P J ^b   Wood, S ^a   Thomson, N C ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; ROSIGLITAZONE;

ADULT; ARTICLE; ASTHMA; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG RESPONSE; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MALE; PATIENT COMPLIANCE; PERIORBITAL EDEMA; PHARYNGITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; VOMITING;

ADULT; ASTHMA; BRONCHODILATOR AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PPAR GAMMA; SMOKING; THIAZOLIDINEDIONES;

EID: 67650617728     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2009.41     Document Type: Article

References (30)

1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention (2008). .
2. Chalmers, G.W., Macleod, K.J., Little, S.A., Thomson, L.J., McSharry, C.P. & Thomson, N.C. Infuence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax 57, 226-230 (2002).
3. Tomlinson, J.E., McMahon, A.D., Chaudhuri, R., Thompson, J.M., Wood, S.F. & Thomson, N.C. Efcacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax 60, 282-287 (2005).
4. Lazarus, S.C. et al. Smoking afects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am. J. Respir. Crit. Care Med. 175, 783-790 (2007).
5. Chaudhuri, R., Livingston, E., McMahon, A.D., Thomson, L., Borland, W. & Thomson, N.C. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am. J. Respir. Crit. Care Med. 168, 1308-1311 (2003).
6. Thomson, N.C. & Spears, M. The infuence of smoking on the treatment response in patients with asthma. Curr. Opin. Allergy Clin. Immunol. 5, 57-63 (2005).
7. Lange, P. , Parner, J., Vestbo, J., Schnohr, P. & Jensen, G. A 15-year follow-up study of ventilatory function in adults with asthma. N. Engl. J. Med. 339, 1194-1200 (1998).
8. Eisner, M.D. & Iribarren, C. The infuence of cigarette smoking on adult asthma outcomes. Nicotine Tob. Res. 9, 53-56 (2007).
9. Chaudhuri, R. et al. Role of symptoms and lung function in determining asthma control in smokers with asthma. Allergy 63, 132-135 (2008).
10. Thomson, N.C. Smokers with asthma: what are the management options? Am. J. Respir. Crit. Care Med. 175, 749-750 (2007).
11. Chaudhuri, R. et al. Efects of smoking cessation on lung function and airway infammation in smokers with asthma. Am. J. Respir. Crit. Care Med. 174, 127-133 (2006).
12. Spears, M., McSharry, C. & Thomson, N.C. Peroxisome proliferator-activated receptor-γ agonists as potential anti-infammatory agents in asthma and chronic obstructive pulmonary disease. Clin. Exp. Allergy 36, 1494-1504 (2006).
13. Spears, M. et al. Efect of theophylline plus beclometasone on lung function in smokers with asthma-a pilot study. Eur. Respir. J. (2009); e-pub ahead of print 5 February 2009.
14. Chung, K.F. et al. Difcult/therapy-resistant asthma: the need for an integrated approach to defne clinical phenotypes, evaluate risk factors, understand pathophysiology and fnd novel therapies. ERS Task Force on Difcult/ Therapy-Resistant Asthma. European Respiratory Society. Eur. Respir. J. 13, 1198-1208 (1999).
15. Juniper, E.F., Price, D.B., Stampone, P.A., Creemers, J.P., Mol, S.J. & Fireman, P. Clinically important improvements in asthma-specifc quality of life, but no diference in conventional clinical indexes in patients changed from conventional beclomethasone dipropionate to approximately half the dose of extrafne beclomethasone dipropionate. Chest 121, 1824-1832 (2002).
16. Cox, G. et al. Asthma control during the year after bronchial thermoplasty. N. Engl. J. Med. 356, 1327-1337 (2007).
17. Morjaria, J.B., Chauhan, A.J., Babu, K.S., Polosa, R., Davies, D.E. & Holgate, S.T. The role of a soluble TNF-α receptor fusion protein (etanercept) in corticosteroid refractory asthma: a double blind, randomised, placebo controlled trial. Thorax 63, 584-591 (2008).
18. Ito, K., Chung, K.F. & Adcock, I.M. Update on glucocorticoid action and resistance. J. Allergy Clin. Immunol. 117, 522-543 (2006).
19. Matthews, L., Berry, A., Tersigni, M., D'Acquisto, F., Ianaro, A. & Ray, D. Thiazolidinediones are partial agonists for the glucocorticoid receptor. Endocrinology 150, 75-86 (2009).
20. Ogawa, S. et al. Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 122, 707-721 (2005).
21. Hamid, Q. et al. Infammation of small airways in asthma. J. Allergy Clin. Immunol. 100, 44-51 (1997).
22. Hogg, J.C. et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 350, 2645-2653 (2004).
23. Shaw, R.J., Djukanovic, R., Tashkin, D.P., Millar, A.B., du Bois, R.M. & Orr, P.A. The role of small airways in lung disease. Respir. Med. 96, 67-80 (2002).
24. Nie, M., Corbett, L., Knox, A.J. & Pang, L. Diferential regulation of chemokine expression by peroxisome proliferator-activated receptor-γ agonists: interactions with glucocorticoids and β2-agonists. J. Biol. Chem. 280, 2550-2561 (2005).
25. Palmer, C.N. et al. PPARG locus haplotype variation and exacerbations in asthma. Clin. Pharmacol. Ther. 81, 713-718 (2007).
26. Benayoun, L. et al. Regulation of peroxisome proliferator- activated receptor-? expression in human asthmatic airways. Relationship with proliferation, apoptosis, and airway remodeling. Am. J. Respir. Crit. Care Med. 164, 1487-1494 (2001).
27. Standardization of spirometry - 1987 update. Statement of the American Thoracic Society. Am. Rev. Respir. Dis. 136, 1285-1298 (1987).
28. Juniper, E.F., O'Byrne, P.M., Guyatt, G.H., Ferrie, P.J. & King, D.R. Development and validation of a questionnaire to measure asthma control. Eur. Respir. J. 14, 902-907 (1999).
29. Vanden Burgt, J., Busse, W.W., Martin, R.J., Szefer, S.J. & Donnell, D. Efcacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofuoroalkane-beclomethasone extrafne inhalation aerosol), in asthma. J. Allergy Clin. Immunol. 106, 1209-1226 (2000).
30. Pavord, I.D., Pizzichini, M.M., Pizzichini, E. & Hargreave, F.E. The use of induced sputum to investigate airway infammation. Thorax 52, 498-501 (1997).